ERBB2 and breast cancer: In the presence of HER2 expression, mucin levels decreased with a simultaneous decrease in the levels of free estrogen and progesterone and an increase in the content of pro-inflammatory cytokines and free amino acids, which was consistent with the aggressive growth pattern and high invasiveness of HER2-positive breast cancer subtypes.